Rossen Janne, Østborg Tilde B, Lindtjørn Elsa, Schulz Jørn, Eggebø Torbjørn M
Department of Obstetrics and Gynecology, Sørlandet Hospital HF, Kristiansand, Norway.
Department of Laboratory Medicine, Children's and Women's Health, Norwegian University of Science and Technology, Trondheim, Norway.
Acta Obstet Gynecol Scand. 2016 Mar;95(3):355-61. doi: 10.1111/aogs.12821. Epub 2015 Dec 8.
A protocol including judicious use of oxytocin augmentation was investigated to determine whether it would change how oxytocin was used and eventually influence labor and fetal outcomes.
The population of this cohort study comprised 20 227 delivering women with singleton pregnancies ≥37 weeks, cephalic presentation, spontaneous or induced onset of labor, without previous cesarean section. Women delivering from 2009 to 2013 at Stavanger University Hospital, Norway, were included. Data were collected prospectively. Before implementing the protocol in 2010, oxytocin augmentation was used if progression of labor was perceived as slow. After implementation, oxytocin could only be started when the cervical dilation had crossed the 4-h action line in the partograph.
The overall use of oxytocin augmentation was significantly reduced from 34.9% to 23.1% (p < 0.01). The overall frequency of emergency cesarean sections decreased from 6.9% to 5.3% (p < 0.05) and the frequency of emergency cesarean sections performed due to fetal distress was reduced from 3.2% to 2.0% (p = 0.01). The rate of women with duration of labor over 12 h increased from 4.4% to 8.5% (p < 0.01) and more women experienced severe estimated postpartum hemorrhage (2.6% vs. 3.7%; p = 0.01). The frequency of children with pH <7.1 in the umbilical artery was reduced from 4.7% to 3.2% (p < 0.01).
The frequency of emergency cesarean section was reduced after implementing judicious use of oxytocin augmentation. Our findings may be of interest in the ongoing discussion of how the balanced use of oxytocin for labor augmentation can best be achieved.
研究了一项包括合理使用缩宫素加强宫缩的方案,以确定其是否会改变缩宫素的使用方式,并最终影响分娩和胎儿结局。
这项队列研究的对象包括20227名单胎妊娠≥37周、头先露、自然发动或引产、既往无剖宫产史的分娩妇女。纳入2009年至2013年在挪威斯塔万格大学医院分娩的妇女。前瞻性收集数据。在2010年实施该方案之前,如果认为产程进展缓慢,则使用缩宫素加强宫缩。实施后,只有当宫颈扩张越过产程图上的4小时行动线时才能开始使用缩宫素。
缩宫素加强宫缩的总体使用率从34.9%显著降至23.1%(p<0.01)。急诊剖宫产的总体发生率从6.9%降至5.3%(p<0.05),因胎儿窘迫而行急诊剖宫产的发生率从3.2%降至2.0%(p=0.01)。产程持续超过12小时的妇女比例从4.4%增至8.5%(p<0.01),更多妇女发生严重估计产后出血(2.6%对3.7%;p=0.01)。脐动脉pH<7.1的新生儿比例从4.7%降至3.2%(p<0.01)。
实施合理使用缩宫素加强宫缩后,急诊剖宫产的发生率降低。我们的研究结果可能有助于正在进行的关于如何最佳实现缩宫素在引产中平衡使用的讨论。